Share Twitter LinkedIn Facebook Email Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology Discusses Von Hippel-Lindau Disease. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on September 22, 2018.
Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read
Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI Kidney 3 Mins Read
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read